The Effect of 2-Amino-3-Arsonopropionate and 2-Amino-4-Arsonobutyrate on the Development and Maintenance of Amygdala Kindled Seizures

References

• Abdul-Ghani A.-S., Attwell P. J. E., Bradfrod H. F. The antiepileptic effect of 3-aminopropylarsonate on electrically kindled amygdala. Brain Research 1996; 742: 305–312
   PubMedGoogle Scholar
• Abdul-Ghani A.-S., Attwell P. J. E., Kent N. S., Bradford H. F., Croucher M. J., Jane D. E. Anti-epileplogenic & anti-convulsant activity of L-2-amino-4-phosphono-butyrate, a presynaptic glutamate receptor agonist. Bruin Research 1997a; 755: 202–212
   PubMedGoogle Scholar
• Abdul-Ghani A.-S., Attwell P. J. E., Bradford H. F. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. European Journal of Pharmacology 1997b; 326: 7–14
   PubMedGoogle Scholar
• Akiyama K., Daigen A., Yamada N., Itoh T., Kohira I., Ujike H., Otsuki S. Long lasting enhancement of metabotropic excitatory amino acid receptor-mediated polyphosphoinositide hydrolysis in the amygdala/pyriform cortex of deep prepiriform cortical kindled rats. Brain Research 1992; 569: 71–77
   PubMedGoogle Scholar
• Albertson T. E., Peterson S. L., Stark L. G. Anticonvulsant drugs & their antagonism of kindled amygdaloid seizures in rats. Neuropharmacology 1980; 19(7)643–652
   PubMedGoogle Scholar
• Albright P. S., Burnham W. M. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical and amygdala-kindled seizures in the rat. Epilepsia 1980; 21: 681–689
   PubMed Web of Science ®Google Scholar
• Ali B. R. S. Enzymatic interactions with arsenical analogues of natural prodects. University of Cambridge. 1993, Ph. D. Thesis
   Google Scholar
• Attwell P. J. E., Kaura S., Sigala G., Bradford H. F., Croucher M. J., Jane D. E., Watkins J. C. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Research 1995; 698: 155–162
   PubMedGoogle Scholar
• Attwell P. J. E., Koumentaki A., Abdul-Ghani A.-S., Croucher M. J., Bradford H. F. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Research 1998a; 787(2)286–291
   PubMedGoogle Scholar
• Attwell P. J. E., Singh-Kent N., Jane D. E., Croucher M. J., Bradford H. F. Anticonvulsant & glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist. Brain Research 1998b, (In Press)
   Google Scholar
• Baskys A., Malenka R. C. Trans-ACPD depresses synaptic transmission in the hippocampus. European Journal Pharmacology 1991; 193: 131–132
   PubMedGoogle Scholar
• Bradford H. F., Dodd P. R. Biochemistry and basic mechanisms of epilepsy. Biochemistry and Neurological Diseases, A. N. Davison. Blackwell, Oxford 1976; 114–168, 1976
   Google Scholar
• Bradford H. F., Peterson D. W. Current views of the pathobiochemistry of epilepsy. Molecular Aspects of Medicine 1987; 9: 119–172
   PubMedGoogle Scholar
• Bradford H. F. Glutamate, GABA and Epilepsy. Progress in Neurobiology 1995; 47: 477–511
   PubMed Web of Science ®Google Scholar
• Cain D. P., Dosborough K. A., McKitrick D. J. Retardation of amygdala kindling by antagonism of NMDA and muscarinic cholinergic receptors. Experimental Neurology 1988; 100: 179–187
   PubMedGoogle Scholar
• Cartmell J., Curtis A. R., Kemp J. A., Kendall D. A., Alexander S. P. H. Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue 1-aminocyclopentane-1,3-dicarboxylate. Neuroscience Letters 1993; 153: 107–110
   PubMedGoogle Scholar
• Chapman A. G., Keane P. E., Meldrum B. S. Mechanism of anticonvulsant action of valproate. Progr. Neurobiology 1982; 19: 315–359
   PubMed Web of Science ®Google Scholar
• Chapman A. G., Graham J., Meldrum B. S. Potent oral anticonvulsant action of CPP and CPP-ene in DBA/2 mice. European Journal Pharmacology 1909; 178(1)97
   Google Scholar
• Coutinho-Netto J., Abdul-Ghani A.-S., Collins J. F., Bradford H. F. Is glutamate a trigger factor in epileptic hyperactivity. Epilepsia 1981; 22: 289–296
   PubMedGoogle Scholar
• Croucher M. J., Collins J. F., Meldrum B. S. Anticonvulsant action of excitatory amino acid antagonists. Science 1982; 216: 899–901
   PubMed Web of Science ®Google Scholar
• Croucher M. J., Meldrum B. S. The role of dicarboxylic amino acids in epilepsy, and the use of antagonists as antiepileptic agents. Neurotransmitters, Seizures and Epilepsy II, R. G. Fariello. Raven Press, New York 1984; 227–236
   Google Scholar
• Croucher M. J., Bradford H. F., Sunter D. C., Watkins J. C. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acids antagonists. European Journal Pharmacology 1988; 152: 29–38
   PubMedGoogle Scholar
• Croucher M. J., Bradford H. F. Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala. Brain Research 1989; 501: 58–65
   PubMedGoogle Scholar
• Croucher M. J., Bradford H. F. The influence of strychnine-insensetive glycine receptor agonists and antagonists on generalized seizure thresholds. Brain Research 1991; 543: 91–96
   PubMedGoogle Scholar
• Croucher M. J., Cotterell K. L., Bradford H. F. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochemistry Research 1992; 17: 409–413
   PubMedGoogle Scholar
• Croucher M. J., Cotterell K. L., Bradford H. F. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. European Journal of Pharmacology 1995; 286: 265–271
   PubMedGoogle Scholar
• Curtis D. R., Watkins J. C. Analogues of glutamic acid and GABA having potent actions on mammalian neurons. Nature 1961; 191: 1010
   PubMedGoogle Scholar
• Dixon H. B. F. The artificial biochemistry of arsenic, especially arsonic acids. Advances in Inorganic Chemistry 1996, (In Press)
   Google Scholar
• Durmuller N., Craggs M., Meldrum B. S. The effect of the non-NMDA receptor antagonist GYK1 52466 and VBQX and the competitive receptor antagonist D-CPPene on the development of amygdala-kindled seizures. Epilepsy Research 1994; 17: 167–174
   PubMed Web of Science ®Google Scholar
• Goddard G., McIntyre D., Leech C. A permanent change in brain function resulting from daily electrical stimulation. Expl. Neurology 1969; 25: 295–330
   PubMed Web of Science ®Google Scholar
• Jung M. J., Lippert B., Metcalf B. W., Bohlen P., Schechter B. J. μ-Vinyl GABA (4- amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effect on brain GABA metabolism in mice. Journal Neurochemistry 1977; 29: 797–802
   PubMed Web of Science ®Google Scholar
• Kaura S., Bradford H. F., Young A. M. J., Croucher M. J., Hughes P. D. Effects of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: In vitro and in vivo studies. J. Neurochem. 1994; 65: 1240–1249
   Google Scholar
• Kerr D. I., Ong J., Prager R. H. Antagonism of GABAB-receptor-mediated responses in guinea-pig isolated ileum and vas deferens by phosphono-analogues of GABA. Brain Journal of Pharmacology 1990; 99(2)422–426
   PubMedGoogle Scholar
• Lacoste A.-M., Dumora C., Ali B. R. S., Neuzil E., Dixon H. B. F. Utilization of 2- amino ethyl arsonic acid in Pseudomonas aeruginosa. Journal of General Microbiology 1992; 138: 1283–1287
   PubMedGoogle Scholar
• Meldrum B. S., Croucher M. J., Badman G., Collins J. F. Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon. Papio Papio Neuroscience Letters 1983; 39: 101–104
   PubMedGoogle Scholar
• Meldrum B. S., Braestrup C. GABA and the anticonvulsant action of benzodiazepines and related drugs. Actions and Interactions of GABA and Benzodiazepines, N. G. Bowery. Raven Press, New York 1984; 133–153
   Google Scholar
• Meldrum B. S. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. British Journal Clinical Pharmacology 1989; 27: 3–11, (Supp. 1)
   Google Scholar
• Meldrum B. S., Chapman A. G., Patel S., Swan J. Competetive NMDA antagonists as drugs. The NMDA Receptors, J. C. Watkins, G. L. Collingridge. Oxford Univ. Press. 1989; 207
   Google Scholar
• Patel S., Chapman A. G., Graham J. L., Meldrum B. S., Fray P. Anticonvulsant activity of the NMDA antagonists, D-(-)4-(3 phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D-(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Research 1990; 7: 3–10
   PubMed Web of Science ®Google Scholar
• Peterson D. W., Collins J. F., Bradford H. F. The kindling amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Research 1983; 275: 169–172
   PubMedGoogle Scholar
• Pook P. C. K., Sunter D. C., Udvarhelyi P. M., Watkins J. C. Evidence for presynaptic depression of monosynaptic excitation in neonatal rate motoneurons by (1S,3S)- and (1S,3R)-ACPD. Experimental Physiology 1992; 77: 529–532
   PubMedGoogle Scholar
• Racine R. J. Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr, Clinical, Neurophysiology 1972; 32: 281–294
   PubMedGoogle Scholar
• Rainnie D. G., Shinnick-Gallagher P. Trans-ACPD and L-APB presynaptically inhibit excitatory glutamatergic transmission in the basolateral amygdala (BLA). Neuroscience Letters 1992; 139: 87–91
   PubMedGoogle Scholar
• Ribak C. E., Harris A. B., Vaughn J. E., Roberts E. Inhibitory GABAergic nerve terminals decrease at sites of focal epilepsy. Science 1979; 205: 211–214
   PubMedGoogle Scholar
• Roberts E. GABA-related phenomena, models of nervous system function, and seizures. Ann. Neurology 1984; 16: 77–89, (Suppl.)
   Google Scholar
• Schwark W., Haluska M. Prophylaxis of amygdala kindling-induced epileptogenesis. Comparison of a GABA uptake inhibitor and diazepam. Epilepsy Research 1987; 1: 63–69
   PubMedGoogle Scholar
• Shin C., Rigsbee L. C., McNamara J. O. Anti-seizure and antiepileptogenic effect of gamma-vinyl GABA in amygdaloid kindling. Brain Research 1986; 398: 370–374
   PubMed Web of Science ®Google Scholar
• Wada J. Pharmacological prophylaxis in the kindling model of epilepsy. Archives Neurology 1977; 34: 389–395
   PubMed Web of Science ®Google Scholar